メニュー
Meet the Program Commitee for 2021!
プログラム委員会
-
Magda Chlebus, MA • Executive Director, Science Policy & Regulatory Affairs
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium -
Inaki Gutierrez-Ibarluzea • Director of organizational innovation and management
BIOEF, Spain -
Sabine Haubenreisser, PHD, MSC • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands -
Esa Henrik Heinonen, DrMed • Director, Assessment of Medicinal Products
Finnish Medicines Agency (Fimea), Finland -
Claire Hill-Venning, PHD • Senior Director Regulatory Policy
Janssen, United Kingdom -
Hubert Leufkens, PHARMD, PHD • Emeritus Professor of Pharmaceutical Policy and Regulatory Science
Utrecht University, Netherlands -
Alexander Natz, JD • Secretary General
European Confederation of Pharmaceutical Entrepreneurs, Belgium -
Lorraine Nolan, PHD • Chief Executive
Health Products Regulatory Authority , Ireland -
Susanne Ausborn, PHD • Global Head International Regulatory Policy
Roche, Switzerland -
Andrew Bate, PHD, MA • Vice President, Head of Safety Innovation and Analytics
GSK, United Kingdom -
Simon Bennett, MSC • Director, EU Regulatory Policy
Biogen, United Kingdom -
Susan Bhatti, PHD • Director EU Global Regulatory and Scientific Policy, Global Regulatory Affairs
Merck BV, Netherlands -
Patrick Brady, PHARMD • Global Head, Therapeutic Innovation & Regulatory Science
IQVIA, United States -
Gabriele Braeunlich, PHD • Head Regulatory Affairs Strategy
Bayer AG, Germany -
Mireille Collombat, PHARMD • Senior Director Group Leader, Global Drug Regulatory Affairs
Actelion Pharmaceuticals Ltd., Switzerland -
Emma Du Four, MBA • Independent Regulatory and R&D Policy Professional
Independent, United Kingdom -
Benjamin Horbach, MSC • Health Systems Strategy Leader - Personalised Healthcare
F. Hoffmann-La Roche, Switzerland -
Jürgen Kübler, PHD • Owner
Quantitative Scientific Consulting, Germany -
Frank Montgomery, PHD • Global Head Regulatory CMC, GRAPSQA
AstraZeneca, United Kingdom -
Paolo Morgese, MSC • Head of Public Affairs
Alliance for Regenerative Medicine (ARM), Belgium -
Mireille Muller, DRSC, PHD, MSC • Regulatory Policy & Intelligence Director
Novartis Pharma AG, Switzerland -
Dolores Hernan Perez de la Ossa, PHD • Quality Specialist - Pharmaceutical Quality Office
European Medicines Agency, Netherlands -
Gavin Outteridge, MA • Managing Director
AESARA Europe, United Kingdom -
Florence Roizard, PHARMD • Vice President, Regulatory Affairs International
MSD France, France -
Oliver Sude, PHD • Legal Counsel, EU Affairs
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Belgium -
Hans van Bruggen, MSC • Director of Regulatory Affairs
Celegence, United States -
Willemijn van der Spuij, MSC • Executive Director Europe | International - Patient Safety
Bristol Myers Squibb, Switzerland -
Andrew Thomson, PHD, MA, MS • Statistician, Methodology Taskforce
European Medicines Agency, Netherlands